IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-14.72%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$9.59M
AUM Growth
+$9.59M
(-98%)
Cap. Flow
-$470M
Cap. Flow
% of AUM
-4,907.13%
Top 10 Holdings %
Top 10 Hldgs %
47.01%
Holding
85
New
15
Increased
1
Reduced
62
Closed
7
Top Buys
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$620K |
| 2 |
Exelixis
EXEL
|
$350K |
| 3 |
Caribou Biosciences
CRBU
|
$255K |
| 4 |
Galapagos
GLPG
|
$123K |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$60K |
Top Sells
| 1 |
Dyne Therapeutics
DYN
|
$68.7M |
| 2 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
$61.1M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
$42.8M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$38.7M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$20.4M |
Sector Composition
| 1 | Healthcare | 91.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Legend Biotech
LEGN
$6.64B
| $4.5K | 0.05% |
248
-4,252
| -94% | -$77.2K |
|
|
TSVT
77
DELISTED
2seventy bio
TSVT
| $3.67K | 0.04% |
48
-3,618
| -99% | -$276K |
|
78
Nkarta
NKTX
$149M
| – | – |
-10,034
| Closed | -$209K |
|
79
Oric Pharmaceuticals
ORIC
$1.03B
| – | – |
-176,217
| Closed | -$905K |
|
80
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-25,122
| Closed | -$3.23M |
|
|
HARP
81
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – |
-15,145
| Closed | -$2.77M |
|
|
GBT
82
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-151,800
| Closed | -$1.64M |
|
|
TPTX
83
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| – | – |
-14,093
| Closed | -$8.68M |
|
|
BHVN
84
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-130,900
| Closed | -$9.29M |
|